These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1960992)
21. The influence of preoperative shock on outcome in sequential endocardial resection for ventricular tachycardia. Hobson CE; DiMarco JP; Haines DE; Flanagan TL; Kron IL J Thorac Cardiovasc Surg; 1991 Sep; 102(3):348-53; discussion 353-4. PubMed ID: 1881175 [TBL] [Abstract][Full Text] [Related]
22. Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival. Marchlinski FE; Waxman HL; Buxton AE; Josephson ME J Am Coll Cardiol; 1983 Aug; 2(2):240-50. PubMed ID: 6863760 [TBL] [Abstract][Full Text] [Related]
23. Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillation. Echt DS; Shapiro M; Trusso J; Mason JW; Winkle RA Am Heart J; 1985 Jan; 109(1):28-33. PubMed ID: 3966329 [TBL] [Abstract][Full Text] [Related]
24. Clinical predictors of arrhythmia inducibility in survivors of cardiac arrest: importance of gender and prior myocardial infarction. Freedman RA; Swerdlow CD; Soderholm-Difatte V; Mason JW J Am Coll Cardiol; 1988 Oct; 12(4):973-8. PubMed ID: 3417994 [TBL] [Abstract][Full Text] [Related]
25. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Liem LB; Swerdlow CD Am J Cardiol; 1988 Sep; 62(9):611-6. PubMed ID: 3414554 [TBL] [Abstract][Full Text] [Related]
26. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia. Waller TJ; Kay HR; Spielman SR; Kutalek SP; Greenspan AM; Horowitz LN J Am Coll Cardiol; 1987 Jul; 10(1):83-9. PubMed ID: 3597999 [TBL] [Abstract][Full Text] [Related]
29. Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. Jazayeri MR; Van Wyhe G; Avitall B; McKinnie J; Tchou P; Akhtar M J Am Coll Cardiol; 1989 Sep; 14(3):705-11; discussion 712-4. PubMed ID: 2768720 [TBL] [Abstract][Full Text] [Related]
30. [Immunosuppressive therapy for effective suppression of life threatening ventricular tachyarrhythmias in chronic myocarditis]. Vester EG; Klein RM; Kühl U; Schultheiss HP; Perings C; Hennersdorf M; Ganschow US; Schannwell CM; Strauer BE Z Kardiol; 1997 Apr; 86(4):298-308. PubMed ID: 9235802 [TBL] [Abstract][Full Text] [Related]
31. Adjuvant metoprolol improves efficacy of class I antiarrhythmic drugs in patients with inducible sustained monomorphic ventricular tachycardia. Brodsky MA; Chough SP; Allen BJ; Capparelli EV; Orlov MV; Caudillo G Am Heart J; 1992 Sep; 124(3):629-35. PubMed ID: 1514490 [TBL] [Abstract][Full Text] [Related]
32. Treatment of life-threatening ventricular arrhythmias with nonguided surgery supported by electrophysiologic testing and drug therapy. Zee-Cheng CS; Kouchoukos NT; Connors JP; Ruffy R J Am Coll Cardiol; 1989 Jan; 13(1):153-62. PubMed ID: 2909563 [TBL] [Abstract][Full Text] [Related]
33. Sustained tachyarrhythmia in children younger than 1 year of age: Six year single-center experience. Tunca Sahin G; Ozturk E; Kasar T; Guzeltas A; Ergul Y Pediatr Int; 2018 Feb; 60(2):115-121. PubMed ID: 29068108 [TBL] [Abstract][Full Text] [Related]
34. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteria. Mitchell LB; Sheldon RS; Gillis AM; Connolly SJ; Duff HJ; Gardner MJ; Hui WK; Ramadan D; Wyse DG J Am Coll Cardiol; 1997 Nov; 30(5):1346-53. PubMed ID: 9350938 [TBL] [Abstract][Full Text] [Related]
35. De novo refractory ventricular tachyarrhythmias after coronary revascularization. Topol EJ; Lerman BB; Baughman KL; Platia EV; Griffith LS Am J Cardiol; 1986 Jan; 57(1):57-9. PubMed ID: 3484603 [TBL] [Abstract][Full Text] [Related]
36. Surgical intervention for drug-resistant ventricular tachycardia. Landymore RW; Gardner MA; McIntyre AJ; Barker RA J Am Coll Cardiol; 1990 Jul; 16(1):37-41. PubMed ID: 2358599 [TBL] [Abstract][Full Text] [Related]
37. Sustained ventricular tachyarrhythmias within 2 months of acute myocardial infarction: results of medical and surgical therapy in patients resuscitated from the initial episode. DiMarco JP; Lerman BB; Kron IL; Sellers TD J Am Coll Cardiol; 1985 Oct; 6(4):759-68. PubMed ID: 4031290 [TBL] [Abstract][Full Text] [Related]
38. Multiple myocardial hamartomas causing ventricular tachycardia in young children: combined surgical modification and medical treatment. Gharagozloo F; Porter CJ; Tazelaar HD; Danielson GK Mayo Clin Proc; 1994 Mar; 69(3):262-7. PubMed ID: 8133664 [TBL] [Abstract][Full Text] [Related]
39. Is surgery for ventricular tachycardia too risky? van Hemel NM Clin Cardiol; 1991 May; 14(5):422-4. PubMed ID: 2049893 [TBL] [Abstract][Full Text] [Related]
40. Reproducibility of successful drug trials in patients with inducible sustained ventricular tachycardia. Fogoros RN; Elson JJ; Bonnet CA; Fiedler SB; Chenarides JG Pacing Clin Electrophysiol; 1992 Mar; 15(3):295-303. PubMed ID: 1372724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]